Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jose Pedro Guerreiro"'
Autor:
Labib AL‐Musawe, Carla Torre, Jose Pedro Guerreiro, Antonio Teixeira Rodrigues, Joao Filipe Raposo, Helder Mota‐Filipe, Ana Paula Martins
Publikováno v:
Pharmacology Research & Perspectives, Vol 8, Iss 4, Pp n/a-n/a (2020)
Abstract The aim of the study is to investigate the patterns of polypharmacy, clinical‐relevant drug‐drug interactions (DDIs), and potentially inappropriate medicines (PIMs), and whether polypharmacy, potential serious clinically‐relevant DDIs,
Externí odkaz:
https://doaj.org/article/6dee050c11cd4de4a0270d958ced533a
Autor:
Ana Carmona Araújo, José Pedro Guerreiro, Carolina Bulhosa, Filipa Alves da Costa, João Goulão, Ana Paula Martins
Publikováno v:
Journal of Pharmaceutical Policy and Practice, Vol 17, Iss 1 (2024)
Introduction Although psychoactive medicines (PMed) are needed in several psychiatric conditions, their use and misuse bear risks. We aimed at estimating the prevalence of PMed use and misuse.Methods Data on all PMed prescribed in 2017 and dispensed
Externí odkaz:
https://doaj.org/article/93eeb12aabce4f51a3883ca78f8a94b7
Autor:
Sónia Romano, Luis Monteiro, José Pedro Guerreiro, João Braga Simões, António Teixeira Rodrigues, Nuno Lunet, Julian Perelman
Publikováno v:
PLoS ONE, Vol 19, Iss 3, p e0298181 (2024)
IntroductionWorldwide, demographic ageing is a major social, economic and health challenge. Despite the increase in life expectancy, elderly often live with multiple chronic conditions, exposing them to multiple medications. Concerns have been raised
Externí odkaz:
https://doaj.org/article/86971beaf6284ed6a5329fa2fc5fd3bf
Autor:
Sónia Romano, Luis Monteiro, José Pedro Guerreiro, João Braga Simões, António Teixeira Rodrigues, Nuno Lunet, Julian Perelman
Publikováno v:
PLoS ONE, Vol 19, Iss 3 (2024)
Externí odkaz:
https://doaj.org/article/248f32c1cf364348b44304167468cec5
Autor:
Rita Oliveira, Matilde Monteiro-Soares, José Pedro Guerreiro, Rúben Pereira, António Teixeira-Rodrigues
Publikováno v:
Pharmacy, Vol 12, Iss 1, p 18 (2024)
Observational, cross-sectional prevalence studies are costly and time-consuming. The development of indirect methods estimating prevalence used to obtain faster, less-expensive, and more robust results would be an advantage for several healthcare app
Externí odkaz:
https://doaj.org/article/42b4dfe2336e428480160b6c2827f9a2
Publikováno v:
BMC Health Services Research, Vol 17, Iss 1, Pp 1-11 (2017)
Abstract Background The successful control of cardiovascular diseases at the lowest possible cost requires the use of the most effective and affordable medicines. We aimed to describe the trends in the ambulatory use of medicines for prevention and t
Externí odkaz:
https://doaj.org/article/fb55c1b6bfdd4c8fa5b2e7e24d51df9e
Autor:
Isabel Pimenta Jacinto, Suzete Costa, Maria Rute Horta, Zilda Mendes, Carla Torre, José Pedro Guerreiro, Sónia Isabel Queirós
Publikováno v:
Revista Portuguesa de Farmacoterapia, Vol 7, Iss 3, Pp 16-21 (2015)
Community Pharmacies’ legal framework (regulated by the decree-law nº 307/2007, 31st August) established the possibility of provision of pharmaceutical services to promote health and well-being by pharmacies. Due to its characteristics in terms o
Externí odkaz:
https://doaj.org/article/1fff681237b4402aa8a342855e34a84a
Autor:
Isabel Pimenta Jacinto, Suzete Costa, Maria Rute Horta, Zilda Mendes, Carla Torre, José Pedro Guerreiro, Sónia Isabel Queirós
Publikováno v:
Revista Portuguesa de Farmacoterapia, Vol 7, Iss 3 (2015)
O regime jurídico das farmácias de oficina, previsto no Decreto-Lei n.º 307/2007, de 31 de agosto, consagrou a possibilidade de as farmácias prestarem serviços farmacêuticos de promoção da saúde e do bem-estar dos utentes. As farmácias, pe
Externí odkaz:
https://doaj.org/article/9e33e219167d405592428012e23d9cb6